Physician profile
John C Brown
NPI 1083617765
$439.03
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.05 · 2020: $70.85 · 2021: $273 · 2022: $18.62.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $185.66 | 2020-2022 | |
| Abbvie INC. | $71.66 | 2021 | |
| Arbor Pharmaceuticals, INC. | $34.81 | 2019 | |
| Edwards Lifesciences Corporation | $34.16 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.14 | 2019 | |
| Ibsa Pharma INC. | $22.36 | 2020 | |
| Abbott Laboratories | $17.65 | 2021 | |
| Almatica Pharma LLC | $17.02 | 2021 | |
| Astellas Pharma US INC | $15.10 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.47 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.